EP08.02-035. Clinical Utility of Liquid Biopsy After Progression to First and Second-Generation TKIs in Advanced EGFR Mutant NSCLC Patients
Back to course
Pdf Summary
Asset Subtitle
David Heredia
Meta Tag
Speaker David Heredia
Topic Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
Keywords
Liquid biopsy
EGFR-mutant non-small cell lung cancer
targeted therapy
prognostic implications
predictive implications
oncogenic alterations
T790M mutation
osimertinib
overall survival
disease burden
Powered By